Tirzepatide

What is tirzepatide?

Tirzepatide is a synthetic peptide that acts as a dual agonist at the GLP-1 and GIP receptors. It is one of the most extensively studied compounds in metabolic peptide research, evaluated across the SURMOUNT trial programme, and it is the compound that established dual-receptor targeting as the direction the field would take.

Yes, tirzepatide is a peptide. The question comes up constantly because the compound is discussed alongside small-molecule drugs, but structurally it is a chain of amino acids engineered for receptor selectivity and extended half-life.

Tirzepatide research applications

Research using tirzepatide covers incretin signalling, comparative agonist studies against single-target compounds, glucose regulation, and body composition endpoints. Its value in a comparative design is that it isolates what the GIP receptor contributes, since it differs from semaglutide in exactly one respect.

How tirzepatide works

GLP-1 receptor activation slows gastric emptying and reduces appetite signalling. GIP is the second incretin hormone, and for years it was considered the less interesting of the pair. Co-targeting it alongside GLP-1 turned out to outperform either pathway alone, which is one of the more instructive recent reversals in metabolic pharmacology.

The molecule is engineered for a long half-life, supporting weekly-interval study designs across the published literature.

Buy tirzepatide: specifications

Tirzepatide vs semaglutide

The most searched comparison in this category, and the answer is narrower than the volume of writing on it suggests. Semaglutide is a single GLP-1 agonist with the longest published record. Tirzepatide adds GIP. In head-to-head trial work, the dual-agonist approach produced stronger results on the metabolic endpoints studied, which is why the field moved.

For the version of this comparison written for a general reader, see our guide to peptides for weight loss for women.

Reconstitution and handling

Tirzepatide is supplied lyophilized and requires reconstitution with bacteriostatic water. Add the diluent slowly down the inside wall of the vial, never directly onto the powder, and let it dissolve without shaking. Swirl gently if needed. Healio stocks bacteriostatic water in 3ml vials for this purpose.

Storage and stability

Store the sealed lyophilized vial at minus 20 degrees Celsius, protected from light. Reconstituted solution requires refrigeration and has a much shorter stable window. Repeated freeze and thaw cycles degrade peptide material and should be avoided.

Certificate of analysis for every batch

Every tirzepatide batch is verified by an independent US analytical laboratory before dispatch, with purity quantified by HPLC and identity confirmed by mass spectrometry. Certificates are published at our research page ahead of purchase, not supplied on request afterwards.

This matters more in the metabolic category than anywhere else in the peptide market, because demand has made it the most counterfeited corner of the sector.

Why researchers buy tirzepatide from Healio

Third-party verification on every batch published before you order, minimum 98% purity by HPLC, mass spectrometry identity confirmation, US dispatch, and a curated catalog rather than a general listing. Our comparison of the best peptide companies sets out the criteria we think any supplier should be judged against.

Tirzepatide FAQ

Is tirzepatide a peptide?

Yes. Tirzepatide is a synthetic peptide, a chain of amino acids engineered to activate both the GLP-1 and GIP receptors. The word peptide describes the molecular structure rather than the mechanism.

What is the difference between tirzepatide and retatrutide?

Tirzepatide targets two receptors, GLP-1 and GIP. Retatrutide targets three, adding glucagon. Tirzepatide has substantially more published trial data behind it; retatrutide has the broader mechanism.

What is tirzepatide used for in research?

Incretin signalling studies, comparative agonist work, glucose regulation and body composition research. It is supplied as a laboratory research material only.

How is Healio tirzepatide tested?

By an independent, unaffiliated US laboratory. Purity is measured by HPLC to a minimum of 98% and identity is confirmed by mass spectrometry, with the certificate for each batch published publicly.